
Ufp Technologies (UFPT) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Ufp Technologies in October 2026.
UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.
Ufp Technologies (UFPT) Stock Forecast
Analyst price target, next 12 months
$308.75
+8.5% vs today's $284.50
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Ufp Technologies have a consensus 12-month target of $308.75, above the current price of $284.50.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 30 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying UFP Technologies' stock, anticipating it will rise to $308.75.
Financial Health
UFP Technologies shows strong revenue, solid cash flow, and healthy profit margins, indicating good financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring UFPT
Drug Pricing Deals Drive US Manufacturing in 2025
Johnson & Johnson secured a deal with the U.S. government to lower drug prices in exchange for tariff exemptions, expanding on a major policy trend. This theme identifies opportunities among pharmaceutical companies and domestic manufacturers benefiting from government incentives to onshore production.
Published: 9 January 2026
Explore BasketWhy invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.